Short Interest in Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) Drops By 74.6%

Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIOW) was the target of a significant decline in short interest in the month of January. As of January 30th, there was short interest totaling 1,382 shares, a decline of 74.6% from the January 15th total of 5,449 shares. Based on an average daily trading volume, of 15,250 shares, the short-interest ratio is presently 0.1 days. Based on an average daily trading volume, of 15,250 shares, the short-interest ratio is presently 0.1 days.

Cardio Diagnostics Price Performance

NASDAQ CDIOW opened at $0.02 on Wednesday. The stock’s fifty day moving average price is $0.02 and its 200 day moving average price is $0.02. Cardio Diagnostics has a 1 year low of $0.01 and a 1 year high of $0.09.

Cardio Diagnostics Company Profile

Cardio Diagnostics Holdings, Inc develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc was founded in 2017 and is headquartered in Chicago, Illinois.